Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1995-4-26
|
| pubmed:abstractText |
Recombinant hirudin (RH) is a new anticoagulant for prophylaxis and treatment of venous and arterial thrombosis. To which extent the activated partial thromboplastin time (APTT) is suitable for monitoring of RH has not been properly evaluated. Recently, a capillary whole blood device was developed for bed-side monitoring of the APTT and it was demonstrated that this device was suitable to monitor heparin therapy. However, monitoring of RH was not evaluated.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0340-6245
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
72
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
685-92
|
| pubmed:dateRevised |
2010-3-24
|
| pubmed:meshHeading |
pubmed-meshheading:7900075-Adult,
pubmed-meshheading:7900075-Evaluation Studies as Topic,
pubmed-meshheading:7900075-Female,
pubmed-meshheading:7900075-Hirudin Therapy,
pubmed-meshheading:7900075-Humans,
pubmed-meshheading:7900075-Male,
pubmed-meshheading:7900075-Monitoring, Physiologic,
pubmed-meshheading:7900075-Partial Thromboplastin Time,
pubmed-meshheading:7900075-Recombinant Proteins,
pubmed-meshheading:7900075-Reference Values,
pubmed-meshheading:7900075-Reproducibility of Results
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assays.
|
| pubmed:affiliation |
Centre for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Centre, Amsterdam, The Netherlands.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|